** Shares of Prestige Consumer Healthcare fall 7.4% to $48

** Co reports Q4 revenue of $281.6 mln vs analysts' average estimate of about $282 mln – LSEG-compiled data

** Posts fiscal year 2026 revenue of $1.09 bln, down 4.3% from a year ago; FY profit $3.91 per share vs $4.29 per share a year ago

** Says it will buy Australian skincare firm LaCorium Health in ~$150 mln deal; target generated ~$40 mln in annual revenue

** The transaction, subject to customary conditions, is expected to close in Q2 fiscal 2027

** As of last close, stock down ~16% YTD